Press release
Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Expands with Advanced Biomarker & Imaging Tools | Allergan plc., Pfizer Inc, Gilead Sciences, Inc., Genfit SA
Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market
Non-Alcoholic Steatohepatitis (NASH) therapeutics and diagnostics focus on managing liver inflammation and fibrosis caused by fat accumulation. Diagnostic tools include imaging, liver biopsy, and biomarker assays. Current treatments target metabolic pathways, insulin resistance, and inflammation. Drugs under development include FXR agonists, PPAR modulators, and anti-fibrotic agents. Lifestyle changes remain the cornerstone of therapy. Early detection is vital to prevent progression to cirrhosis or liver cancer.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Landscape:- https://datamintelligence.com/download-sample/non-alcoholic-steatohepatitis-therapeutics-and-diagnostics-market?Ranjith
☛ Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Recent Developments 2025:
United States: Recent Industry Developments
✅ In July 2025, Intercept Pharmaceuticals reported positive Phase 3 results for Ocaliva (obeticholic acid) in patients with NASH and advanced fibrosis, demonstrating improved liver histology and reduced progression to cirrhosis.
✅ In June 2025, Genfit advanced its elafibranor program into late-stage clinical trials, targeting metabolic modulation and inflammation reduction in NASH patients.
✅ In May 2025, Gilead Sciences launched non-invasive diagnostic imaging tools for NASH, enabling earlier detection of liver fibrosis and monitoring of therapeutic efficacy.
Japan: Recent Industry Developments
✅ In July 2025, Daiichi Sankyo initiated clinical trials for a novel dual-action therapy targeting both liver fat accumulation and inflammation in Japanese NASH patients.
✅ In June 2025, Takeda Pharmaceutical developed biomarker-based diagnostic kits for early NASH detection, focusing on precision medicine and non-invasive assessment.
✅ In May 2025, Mitsubishi Tanabe Pharma partnered with hospitals to validate AI-assisted imaging diagnostics for liver fibrosis staging, improving patient stratification and treatment monitoring.
☛ Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Competitive Landscape:
Allergan plc., Pfizer Inc, Gilead Sciences, Inc., Genfit SA, Novartis AG, Intercepts Pharmaceuticals, Cadila Healthcare Ltd, Novo Nordisk, Raptor Pharmaceutical Corp. and Galmed Pharmaceuticals Ltd.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/non-alcoholic-steatohepatitis-therapeutics-and-diagnostics-market?Ranjith
☛ Segments Covered in the Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market:
By Therapeutics: Ocaliva | Elafibranor | Cenicriviroc | Selonsertib | Others
By Diagnostics: Imaging Techniques | Diagnostic Tests | Biopsy
By Sales Channel: Hospital Pharmacy | Online Channel | Retail Channel
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=non-alcoholic-steatohepatitis-therapeutics-and-diagnostics-market?Ranjith
☛ Regional Analysis for Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Expands with Advanced Biomarker & Imaging Tools | Allergan plc., Pfizer Inc, Gilead Sciences, Inc., Genfit SA here
News-ID: 4223245 • Views: …
More Releases from DataM Intelligence 4market Research LLP
U.S. Precision Farming Market to Reach $4.5 Billion by 2030 Leveraging IoT and A …
The U.S. precision farming market is witnessing robust growth driven by the increasing adoption of Internet of Things (IoT) technologies and advanced analytics that optimize farming inputs, labor, and costs in sustainable agricultural practices. DataM Intelligence estimates the market at USD 2.62 billion in 2023, with a projected CAGR of 9.5% from 2024 to 2030, positioning the U.S. as a major global precision farming hub with nearly 25% market share…
U.S. Microgrid as a Service Market Projected to Reach $2.1 Billion by 2030 Fueli …
The U.S. Microgrid as a Service (MaaS) market is expanding rapidly, driven by growing demand for renewable energy integration, resilient power infrastructure, and supportive government incentives. As per DataM Intelligence, the market was valued at approximately USD 953 million in 2024 and is expected to grow at a CAGR of 12.0% from 2025 to 2030, reaching over USD 2.1 billion. This growth reflects the increasing adoption of turnkey MaaS solutions…
U.S. Cosmetics Packaging Market Size to Reach US$ 2.74 Billion by 2030 with Focu …
The U.S. cosmetics packaging market is on a steady growth path, driven by increasing consumer demand for diverse cosmetics products and an expanding beauty industry. DataM Intelligence reports the market valued at $1.85 billion in 2022, expected to reach $2.74 billion by 2030 with a CAGR of 5.02% from 2023 to 2030. As consumers prioritize aesthetics, brand identity, and sustainability, packaging that safeguards products while enhancing visibility and appeal is…
U.S. Mental Health Apps Market Projected to Reach $6.2 Billion by 2030 Driven by …
The U.S. mental health apps market is experiencing rapid growth as technology-driven solutions become critical for addressing the high prevalence of mental illnesses. Valued at $2.6 billion in 2023, DataM Intelligence forecasts the market to reach $6.2 billion by 2030, growing at a CAGR of 13.2%. These apps encompass a variety of formats, including tools for managing depression, anxiety, and insomnia, and offer access to professionals via live chat, video,…
More Releases for Diagnostic
Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804
This latest report researches the industry structure, sales, revenue,…
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688
This latest report researches the industry structure, sales, revenue,…
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of…
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects.
Tenet Diagnostics got its NABL certification in the fastest time and is…
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends…
